Avalyn Pharma Inc. (AVLN:NASDAQ) closed at $28.40 on November 20, 2026, down 1.05% on the day. The stock trades 29.3% below its 52-week high of $40.17 and 27.7% above its 52-week low of $22.24. Over the past year, it lost 3.7%. Avalyn Pharma Inc. is part of the Health Care sector.
In 142 trading sessions since May 1, 2026, AVLN closed higher on 73 days (51%). Its best day was July 17, 2026 (+10.20%) and its worst was May 18, 2026 (-10.76%). The stock moved 10% or more in a single session 2 times.
Avalyn Pharma is a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases including pulmonary fibrosis. In partnership with patients, caregivers and physicians, we are developing innovative inhaled therapies that deliver established antifibrotic medicines directly to the lungs, to improve efficacy, enhance tolerability, and establish a new standard of care for patients.
Find more stocks like AVLN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.